The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
PKM2 mRNA expression to predict disease recurrence in patients with stage II or III colon cancer treated with oxaliplatin in combination with fluoropyrimidines.
Chara Papadaki
No relevant relationships to disclose
Maria Sfakianaki
No relevant relationships to disclose
Zacharenia Saridaki
No relevant relationships to disclose
Georgios Giagas
No relevant relationships to disclose
Kyriakos Mpananis
No relevant relationships to disclose
Maria Tzardi
No relevant relationships to disclose
Eleftheria Tsakalaki
No relevant relationships to disclose
Maria Trypaki
No relevant relationships to disclose
Vassilis Georgoulias
No relevant relationships to disclose
Ioannis Sougklakos
No relevant relationships to disclose